---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-012895"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T12:51:32.823474+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Kala Pharmaceuticals changes name to KALA BIO, Inc.; ticker KALA unchanged

## Summary
- Effective August 2, 2023, name changed from Kala Pharmaceuticals, Inc. to KALA BIO, Inc.
- Ticker symbol remains KALA on Nasdaq; trading under new name starts August 3, 2023.
- Stockholder rights unaffected; CUSIP unchanged.
- Board approved the name change under Delaware law; amended certificate and bylaws filed.

## SEC filing metadata
- accession: 0001558370-23-012895
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000155837023012895/0001558370-23-012895-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000155837023012895/kala-20230802x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-012895
- JSON: https://secwatch.observer/filing/0001558370-23-012895.json
- Plain text: https://secwatch.observer/filing/0001558370-23-012895.txt

## Key facts
- Governance Changes
  KALA BIO, Inc.: Amended certificate of incorporation to change company name from Kala Pharmaceuticals, Inc. to KALA BIO, Inc (effective 2023-08-02).
  - Change: charter amendment
  - Effective: 2023-08-02
  source text: Effective as of 4:00 p.m., Eastern Time on August 2, 2023, Kala Pharmaceuticals, Inc. (the “Company”) amended its Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to effect a change of the Company’s name from “Kala Pharmaceuticals, Inc.” to “KALA BIO, Inc.”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023012895/0001558370-23-012895-index.htm
- Governance Changes
  KALA BIO, Inc.: Amended and restated bylaws solely to reflect name change to KALA BIO, Inc (effective 2023-08-02).
  - Change: bylaw amendment
  - Effective: 2023-08-02
  source text: the Board also approved an amendment and restatement of the Company’s Second Amended and Restated By-Laws solely to reflect the Name Change (as amended and restated, the “Third Amended and Restated By-Laws”) effective as of August 2, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023012895/0001558370-23-012895-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.